BREAKING: The Food and Drug Administration made a regulatory change that will make it possible for retail pharmacies to offer abortion pills in the U.S.
The Food and Drug Administration on Tuesday made a regulatory change that will make it possible for retail pharmacies toUnder the regulatory change, certified pharmacies may dispense mifepristone — which is used with misoprostol in first-trimester abortions — directly to patients after receiving a prescription from a certified health provider, according to a statement from Danco Laboratories, one of the makers of the pill.
The FDA has yet to make an announcement, but the agency is expected to update its website to reflect the change later Tuesday.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Here's What a ‘Self-Managed’ Abortion Actually Means and Entails, According to a Certified Nurse MidwifeThe term self-managed abortion can be confusing. Experts discuss what it actually means, and doesn't mean.
Read more »
House investigation finds FDA, drug firm Biogen ignored internal concerns for Alzheimer's drugA congressional investigation into the FDA's review process for an Alzheimer's treatment found that the agency 'deviated' from its standard procedures to approve the Aduhelm drug with inconsistent data.
Read more »
FDA decision on experimental Alzheimer's drug expected this week | CNNThe US Food and Drug Administration could decide this week whether to grant accelerated approval to the experimental Alzheimer's drug lecanemab, according to Eisai and Biogen, the companies that make the drug.
Read more »
Outdoor retail, new park among the projects to watch in Surprise next yearMore restaurants, stores and family-oriented entertainment are on tap in Surprise.
Read more »
Controversial Alzheimer's drug, explained: What to know about Aduhelm, FDA and scathing reportThe FDA's approval process of Alzheimer’s drug Aduhelm has been deemed “rife with irregularities,” according to a congressional investigation. Here are takeaways from the report.
Read more »